Sanofi joins the digital therapeutics market Tuesday with a proposed app to improve mental health in patients with multiple sclerosis. Created in partnership with established mental health digital therapeutics firm Happify Health, the app is currently in a proof-of-concept online trial with several thousand MS patients.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,